A new therapy for patients with advanced heart failure (HF) involves the implantation of a specialized pacemaker device (Cardiac Resynchronization Therapy, CRT) that attempts to restore the synchronized contraction of the ventricular chambers of the heart. In some people, CRT improves exertional breathlessness and allows them to exercise for longer periods. However, to date, the mechanisms by which CRT improves symptoms and exercise tolerance is unknown. This study will use in-depth cardiopulmonary exercise testing and pulmonary function testing to explore these mechanisms in greater detail.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
2
Initiation of active biventricular pacing/cardiac resynchronization therapy Devices by Medtronic: 1. Insync Sentry 7298 \& 7299 2. Concerto C174 ASK (Most frequently implanted) 3. Insync III 8042 (PM) Devices by Guidant/Boston Scientific: 1. Contak Renewal 4 H190 \& H199 2. Contak Renewal 3 H127 Devices by ELA/Sorin: 1\. Ovatio CRT 6750
Kingston General Hospital
Kingston, Ontario, Canada
Exercise endurance time
Time frame: 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.